Stocks Flat After S&P 3-Day Losing Streak
Stock futures were little changed Tuesday after the S&P 500 posted a three-day losing streak, with traders weighing concerns around global trade.Futures for the Dow Jones Industrials progressed 41 points, or 0.1%, to 43,576Futures for the much-broader index settled 1.75 points to 5,999.Futures for the tech-heavy NASDAQ sank 37.75 points, or 0.2%, to 21,382.50. Bitcoin prices fell below $90,000 overnight, marking their lowest their lowest level in three months. The blue-chip coin is trading almost 20% below its all-time high reached on President Donald Trump’s inauguration day.Investors are also mulling President Donald Trump’s latest remarks on trade. He said that tariffs on imports from Canada and Mexico “will go forward” after the current 30-day moratorium ends.Wall Street also turned its attention to key earnings reports. Home Depot reported fourth-quarter figures that beat analyst expectations, but the stock shed about 2% in the premarket.Nvidia is set to report earnings Wednesday after the bell.On the economic front, investors are turning their attention to the latest U.S. consumer confidence data due out at 10 a.m. ET. Economists polled by Dow Jones are expecting the Conference Board’s consumer confidence index to show a reading of 102.3 for February, less than the previous month’s reading of 104.1.In Japan, markets returned to trading Tuesday, with the Nikkei 225 docked 1.4%, while in Hong Kong, the Hang Seng dipped 1.3%. Oil prices slid 40 cents to $70.30 U.S. a barrel. Gold prices faltered $24.20 to $2,939 U.S. an ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


